title: Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.
abstract: Cancer germline (CG; also known as cancer-testis) antigen genes are normally expressed in germ cells and trophoblast tissues and are aberrantly expressed in a variety of human malignancies. CG antigen genes have high clinical relevance as they encode a class of immunogenic and highly selective tumor antigens. CG antigen-directed immunotherapy is undergoing clinical evaluation for the treatment of a number of solid tumor malignancies and has been demonstrated to be safe, provoke immune responses and be of therapeutic benefit. Achieving an improved understanding of the mechanisms of CG antigen gene regulation will facilitate the continued development of targeted therapeutic approaches against tumors expressing these antigens. Substantial evidence suggests epigenetic mechanisms, particularly DNA methylation, as a primary regulator of CG antigen gene expression in normal and cancer cells as well as in stem cells. The roles of sequence-specific transcription factors and signal transduction pathways in controlling CG antigen gene expression are less clear but are emerging. A combinatorial therapeutic approach involving epigenetic modulatory drugs and CG antigen immunotherapy is suggested based on these data and is being actively pursued. In this article, we review the mechanisms of CG antigen gene regulation and discuss the implications of these mechanisms for the development of cancer immunotherapy approaches targeting CG antigens.
authors.affiliation: Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
authors.forename: Stacey N
authors.initials: SN
authors.lastname: Akers
authors.forename: Kunle
authors.initials: K
authors.lastname: Odunsi
authors.forename: Adam R
authors.initials: AR
authors.lastname: Karpf
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology*; D044127:Epigenesis, Genetic; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000235:genetics* / Q000276:immunology* / Q000628:therapy
chemical_list: D000951:Antigens, Neoplasm
references.citation: Clin Cancer Res. 2004 Feb 1;10(3):890-6
references.pmid: 14871964
references.citation: Clin Cancer Res. 2006 Oct 1;12(19):5777-85
references.pmid: 17020984
references.citation: J Cell Physiol. 2006 Apr;207(1):58-66
references.pmid: 16252259
references.citation: Eur J Clin Invest. 2005 Jun;35(6):380-7
references.pmid: 15948899
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4760-5
references.pmid: 10781081
references.citation: Immunogenetics. 1995;42(4):282-90
references.pmid: 7672823
references.citation: Immunol Rev. 2002 Oct;188:22-32
references.pmid: 12445278
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7
references.pmid: 19088187
references.citation: Cancer Res. 2004 Sep 1;64(17):5988-93
references.pmid: 15342378
references.citation: Genes Dev. 2002 Jul 15;16(14):1779-91
references.pmid: 12130538
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2346-57
references.pmid: 15800326
references.citation: J Invest Dermatol. 2007 Sep;127(9):2123-8
references.pmid: 17495964
references.citation: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10697-702
references.pmid: 15252201
references.citation: Stem Cells. 2009 Apr;27(4):822-4
references.pmid: 19350682
references.citation: Cancer Res. 2005 Sep 1;65(17):7763-74
references.pmid: 16140944
references.citation: Nature. 2004 May 27;429(6990):457-63
references.pmid: 15164071
references.citation: Nat Rev Cancer. 2005 Aug;5(8):615-25
references.pmid: 16034368
references.citation: Int J Cancer. 2008 Feb 15;122(4):777-84
references.pmid: 17957795
references.citation: Oncogene. 2001 May 28;20(24):3139-55
references.pmid: 11420731
references.citation: Science. 2001 Aug 10;293(5532):1074-80
references.pmid: 11498575
references.citation: PLoS One. 2009;4(3):e4961
references.pmid: 19305507
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3283-90
references.pmid: 18519754
references.citation: Epigenomics. 2009 Oct;1(1):153-61
references.pmid: 22122641
references.citation: Oncogene. 2002 Aug 12;21(35):5400-13
references.pmid: 12154403
references.citation: J Immunol. 1999 Nov 15;163(10):5211-8
references.pmid: 10553041
references.citation: Hum Reprod. 2007 Apr;22(4):953-60
references.pmid: 17208940
references.citation: PLoS One. 2009 Dec 04;4(12):e8189
references.pmid: 19997593
references.citation: Curr Opin Genet Dev. 2006 Apr;16(2):137-42
references.pmid: 16503130
references.citation: Mol Cancer Res. 2009 Jun;7(6):851-62
references.pmid: 19531572
references.citation: Blood. 2003 Jun 1;101(11):4644-6; discussion 4645-6
references.pmid: 12756166
references.citation: Cancer Res. 2000 Sep 1;60(17):4946-52
references.pmid: 10987311
references.citation: Mol Cancer. 2007 Feb 02;6:12
references.pmid: 17274819
references.citation: Oncogene. 2003 Sep 29;22(42):6484-8
references.pmid: 14528272
references.citation: J Cell Sci. 2003 Jun 1;116(Pt 11):2117-24
references.pmid: 12730288
references.citation: J Clin Oncol. 2002 Mar 15;20(6):1692-703
references.pmid: 11896121
references.citation: Mol Hum Reprod. 2008 Feb;14(2):107-16
references.pmid: 18048459
references.citation: Mol Cancer Res. 2006 May;4(5):339-49
references.pmid: 16687489
references.citation: Am J Pathol. 2009 Jul;175(1):314-23
references.pmid: 19498007
references.citation: FEBS Lett. 2009 Jun 5;583(11):1713-20
references.pmid: 19376112
references.citation: Nucleic Acids Res. 2007;35(21):7372-88
references.pmid: 17962299
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11160-5
references.pmid: 16847267
references.citation: Mol Cell Biol. 2003 Mar;23(6):1946-60
references.pmid: 12612069
references.citation: J Biol Chem. 2006 Apr 14;281(15):10118-26
references.pmid: 16497664
references.citation: Mol Carcinog. 2010 Jun;49(6):532-44
references.pmid: 20082319
references.citation: Mol Cancer Res. 2009 Apr;7(4):523-35
references.pmid: 19372581
references.citation: Clin Cancer Res. 2009 Sep 1;15(17):5323-37
references.pmid: 19723653
references.citation: Cancer Immun. 2003 Dec 18;3:19
references.pmid: 14680360
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1577-88
references.pmid: 16854382
references.citation: Cancer Res. 2005 Sep 1;65(17):7751-62
references.pmid: 16140943
references.citation: Mol Cancer Ther. 2009 Dec;8(12):3191-202
references.pmid: 19934278
references.citation: Cancer Res. 2005 Mar 15;65(6):2207-15
references.pmid: 15781633
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1914-8
references.pmid: 9050879
references.citation: J Immunother. 2001 Mar-Apr;24(2):151-61
references.pmid: 11265773
references.citation: EMBO J. 2008 Oct 22;27(20):2681-90
references.pmid: 18818694
references.citation: Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R47-58
references.pmid: 15809273
references.citation: J Exp Med. 1998 Jan 19;187(2):265-70
references.pmid: 9432985
references.citation: Nat Immunol. 2000 Dec;1(6):515-20
references.pmid: 11101874
references.citation: Cancer Immunol Immunother. 2009 Apr;58(4):589-601
references.pmid: 18791715
references.citation: Cancer J. 2000 May;6 Suppl 3:S250-8
references.pmid: 10874495
references.citation: Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10067-71
references.pmid: 9707601
references.citation: J Exp Med. 1998 Apr 20;187(8):1349-54
references.pmid: 9547346
references.citation: Oncogene. 2002 Aug 12;21(35):5496-503
references.pmid: 12154410
references.citation: Mol Cancer Ther. 2009 Jun;8(6):1409-20
references.pmid: 19509247
references.citation: Nat Rev Cancer. 2005 May;5(5):397-405
references.pmid: 15864281
references.citation: Mol Cancer Res. 2007 Jul;5(7):749-59
references.pmid: 17634428
references.citation: Clin Cancer Res. 2007 Jun 1;13(11):3333-8
references.pmid: 17545540
references.citation: J Cell Physiol. 2008 May;215(2):287-91
references.pmid: 18205182
references.citation: Science. 1991 Dec 13;254(5038):1643-7
references.pmid: 1840703
references.citation: Oncogene. 2007 Jun 28;26(30):4394-403
references.pmid: 17260018
references.citation: Cancer Immunol Immunother. 2009 Mar;58(3):383-94
references.pmid: 18677478
references.citation: Epigenetics. 2008 Jan-Feb;3(1):38-42
references.pmid: 18094622
references.citation: Semin Cancer Biol. 2002 Oct;12(5):399-414
references.pmid: 12191639
references.citation: Int J Cancer. 1996 Nov 15;68(4):464-70
references.pmid: 8945617
references.citation: Cancer Res. 2002 Jul 1;62(13):3630-5
references.pmid: 12097265
references.citation: Cancer Res. 2003 Sep 15;63(18):6076-83
references.pmid: 14522938
references.citation: Cancer Res. 1994 Apr 1;54(7):1766-71
references.pmid: 7511051
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D816-9
references.pmid: 18838390
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7149-53
references.pmid: 8692960
references.citation: Adv Immunol. 2000;74:181-273
references.pmid: 10605607
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6806-11
references.pmid: 12011441
references.citation: Curr Opin Immunol. 1997 Oct;9(5):702-8
references.pmid: 9368780
references.citation: Mol Pharmacol. 2004 Jan;65(1):18-27
references.pmid: 14722233
references.citation: Genes Dev. 2009 Apr 1;23(7):781-3
references.pmid: 19339683
references.citation: Mol Cell Biol. 2008 Nov;28(21):6720-9
references.pmid: 18765639
references.citation: Cancer Immun. 2007 Dec 21;7:21
references.pmid: 18095639
references.citation: Cancer Res. 2007 Oct 15;67(20):9954-62
references.pmid: 17942928
references.citation: Clin Cancer Res. 2007 Aug 15;13(16):4713-20
references.pmid: 17699848
references.citation: Epigenetics. 2006 Jul-Sep;1(3):116-20
references.pmid: 17786175
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: Cancer Res. 2001 Jul 15;61(14):5544-51
references.pmid: 11454705
references.citation: Cancer Immunol Immunother. 2009 Oct;58(10):1635-46
references.pmid: 19221743
references.citation: Genes Dev. 2005 Apr 1;19(7):815-26
references.pmid: 15774718
references.citation: J Exp Med. 2000 Feb 21;191(4):625-30
references.pmid: 10684854
references.citation: Curr Opin Immunol. 2004 Apr;16(2):157-62
references.pmid: 15023407
references.citation: Cancer Immun. 2004 Jan 23;4:1
references.pmid: 14738373
references.citation: Stem Cells. 2007 Mar;25(3):707-11
references.pmid: 17138959
references.citation: J Immunol. 2000 Jul 15;165(2):1153-9
references.pmid: 10878395
references.citation: Gynecol Oncol. 2010 Feb;116(2):195-201
references.pmid: 19854495
references.citation: Clin Cancer Res. 2008 Apr 1;14(7):1984-96
references.pmid: 18381936
references.citation: Oncogene. 2006 Nov 2;25(52):6975-85
references.pmid: 16715135
references.citation: J Clin Oncol. 2007 Jul 10;25(20):2884-93
references.pmid: 17617519
references.citation: EMBO J. 2008 Oct 22;27(20):2691-701
references.pmid: 18818693
references.citation: Mol Cell Biol. 1999 Nov;19(11):7327-35
references.pmid: 10523621
references.citation: Nat Med. 2003 Oct;9(10):1269-74
references.pmid: 14502282
references.citation: Cancer Res. 2004 Dec 15;64(24):9167-71
references.pmid: 15604288